Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Balancing immunity: disease risk mutation can be beneficial

Trends in Immunology(2025)10.1016/j.it.2025.07.007Source: DataRank Database

Balancing immunity: disease risk mutation can be beneficial is a research paper published in Trends in Immunology (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.00)OA: greenTopics (42)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Richard S. Blumberg ORCID,Xi Lin ORCID

Live enrichment

PubMed:40813227 OpenAlex:https://openalex.org/W4413137519

Crohn's and Colitis Foundation of America

Grant: 1282671

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK088199

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK051362

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK044319

Harvard Digestive Diseases Center

Grant: P30DK034854

NIDDK NIH HHS

Grant: R37 DK044319

NIDDK NIH HHS

Grant: R01 DK088199

NIDDK NIH HHS

Grant: R01 DK051362

NIDDK NIH HHS

Grant: R01 DK044319

FWCI

0.00

Citation Percentile

0.2%

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12505537/

publisherhttps://api.elsevier.com/content/article/PII:S1471490625001747?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1471490625001747?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.it.2025.07.007

Fields of Study

Inflammatory Bowel DiseaseAutoimmune and Inflammatory Disorders ResearchIL-33, ST2, and ILC PathwaysHumansGenetic Predisposition to DiseaseAutophagy-Related ProteinsMutationCrohn DiseaseAutophagyAnimalsAllelesRisk FactorsImmunity

MeSH Terms

Autophagy-Related ProteinsAllelesAnimalsAutophagyCrohn DiseaseHumansImmunityMutationRisk FactorsGenetic Predisposition to Disease

Keywords

AlleleHeterozygote advantageDiseaseATG16L1ImmunologyBiologyImmunityMutationPopulationGeneticsCrohn's diseaseGeneMedicineImmune systemInternal medicineCrohn’s disease (CD)Salmonella infectionautophagyinflammasome

Sustainable Development Goals

SDG 0: Good health and well-being